Home » Topics » BioWorld

BioWorld
RSS

ATS TO COLLABORATE WITH CELL GENESYS

Dec. 31, 1992

ORPHAN DRUG STATUS 1992

Dec. 31, 1992

FDA APPROVES ORPHAN DRUG REGULATIONS

Dec. 31, 1992

FDA APPROVES CYTOGEN'S ONCOSCINT

Dec. 31, 1992

APPOINTMENTS AND ADVANCEMENTS

Dec. 30, 1992

NIH LICENSES PATENT TO DIATECH

Dec. 30, 1992

UNIVAX BEGINS CF INOCULATION PROGRAM

Dec. 30, 1992

EMISPHERE RECEIVES INTERIM PAYMENT

Dec. 30, 1992

GENZYME TO MILK TRANSGENIC BUSINESS

Dec. 30, 1992

FDA APPROVES BRISTOL'S TAXOL

Dec. 30, 1992

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...